October 13, 2015
(GreenMedInfo.com) Up to 90% of colon cancer cases can be linked to diet. Let food be your medicine.
Recently the U.S. Food and Drug Administration approved a new drug for metastatic colon cancer.
[Sponsor Links: Anti-Killer cell Protocol]
Lonsurf is a combination of two drugs, trifluridine and tipiracil. Its most common side effects are life-threatening anemia, a decrease in infection-fighting white blood cells and blood platelets, physical weakness, and extreme fatigue. It also causes nausea, decreased appetite, diarrhea, vomiting, abdominal pain and fever.
The drug maker announced the approval as a milestone offering significant survival benefits to patients. But does it?
A randomized, double-blind study of 800 patients with previously treated advanced colorectal cancer found that patients treated with Lonsurf lived 7.1 months. That compared to 5.3 months for those who took a placebo.
In other words, the drug extended life for less than two months.
Read the rest of this interesting article and then please go to UtopiaSilver.com for health healing protocols and supplements–>